We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Sareum Holdings Plc | LSE:SAR | London | Ordinary Share | GB00BMC3RJ87 | ORD GBP 0.0125 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.50 | -2.04% | 24.00 | 23.00 | 25.00 | 24.50 | 23.00 | 24.50 | 275,939 | 13:19:02 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -3.42M | -0.0317 | -7.57 | 26.45M |
Date | Subject | Author | Discuss |
---|---|---|---|
29/10/2024 22:25 | Oh no... You have been reported as a critical thinker... And then the world will no longer be able to share your wonderful "insights" When's that takeover happening... Get your meds taken and get to bed... More share price falls for you to try and excuse tomorrow... | wolfofwallstreets | |
29/10/2024 21:46 | So you report an individual logged as critical thinker but report as critical stinker...I notice the aliases on lse are in motion. ADVFN effectively with their investments criteria need to clean up here. And lse will see you being silenced will be noteable | criticalthinker1 | |
29/10/2024 21:31 | Just reported you as well criticalstinker.. | wolfofwallstreets | |
29/10/2024 21:26 | Criticalstinker... I can imagine advfn will actively work through the night... I hear emma walmsley is also involved.. Utter loon of a man.. | wolfofwallstreets | |
29/10/2024 21:25 | Yeah...I don't think that's gonna happen... How's your family? Sorry..forgot...they have nothing more to do with you eh hahaha | wolfofwallstreets | |
29/10/2024 21:17 | And you have other logins....well hopefully the ADVFN team can deal with that too! | criticalthinker1 | |
29/10/2024 21:16 | My only social life? I can guarantee you it is not. But that would not deter you from your obvious determination to avoid positive speculation here. I have reported you. Hopefully the ADVFN team see these posts in the morning. | criticalthinker1 | |
29/10/2024 20:19 | No criticalstinker..tha You don't like anyone who isn't a ramper... Stick to your anti vax garbage and chatting about thoth2..this page is your only social life... Report away... Will just use another one of my logins... | wolfofwallstreets | |
29/10/2024 19:54 | So wolf are you saying the individuals and corporate..s ...are putting money into Sareum because they see a means to work the market capital and worth of Sareum? That's libellous chap. You need to report the funding to the relevant body. As the board will have to respond you such an insinuation. Or maybe you get reported for disemmenation of discussion that proports a positive indication. I've not reported anyone yet but this will be my first. | criticalthinker1 | |
29/10/2024 18:38 | I didn't get to view the ivm. But reading some of the posts on lse it seems the ducks are lining up. The toxicology studies will offer a greater platform as a prerequisite to ph2. Some companies have parameters within their own corporate governance and shareholders responsibility as to when they can show their hand! Fact This also will also further validate numerous patents approved and pending. As per the corporate objectives of Sareum this is commensurate with such objectives. Until I get to hear the upload about the inferred potential of more than one pharma actually requesting such requirements then imo its only a matter of time until a bidding scenario commences. It's akin to a poker game. Who shows their hand/interest first...Once that happens then whoosh... All best Steadydanny 👌 | criticalthinker1 | |
29/10/2024 17:27 | The happy clappy rampers will never let reality dampen their spirits lol... | wolfofwallstreets | |
29/10/2024 17:00 | Another great day for sareum... More falls... | wolfofwallstreets | |
29/10/2024 15:56 | well mong, the BOD are just a load of ramping idiots | horridhenry | |
29/10/2024 15:47 | And lse take the little breadcrumbs and the cycle starts over.. Partner companies...opportun Then nothing for months... Then 737 will get handed back... Share price will collapse.. Then they will release some news... Share price recovers... More placings... Then the next annual meeting.. | wolfofwallstreets | |
29/10/2024 15:40 | i'm buying some in a minute, look out for a big buy! | horridhenry | |
29/10/2024 15:38 | had to laugh partner companies haha maybe all the pharmas are going to chip together to license 1801 | iamhappy1 | |
29/10/2024 15:29 | pretty clear that all 3 of our leaders are holding a lot back. There can only be an nda in place The response about a new CEO appointment was telling - no point in several scenarios reassuring i would say | horridhenry | |
29/10/2024 15:12 | Jam tomorrow...the science... | wolfofwallstreets | |
29/10/2024 13:23 | 1* Sareum Holdings plc, a biotechnology company developing next generation kinase inhibitors for autoimmune disease and cancer, posted weak FY numbers for the year ended 30 June 2024 this morning. The Group reported another loss on ordinary activities after taxation for the year ended 30 June 2024 of £3.4 million a little larger than the £3.2 million loss for the year ended 30 June 2023. The business has not managed to generate revenue yet let alone profit and continues to raise funds to exist. Post period end, the Company completed fundraises totalling £3.4 million (before expenses), from certain high net worth individuals, corporates and institutions, via subscriptions for a total of 16,264,444 new ordinary shares... ...from WealthOracle wealthoracle.co.uk/d | martinmc123 | |
29/10/2024 10:51 | Jam tomorrow lol... | wolfofwallstreets | |
29/10/2024 08:09 | Lse really needs workinginpharma back to tell them...wink wink nudge nudge..what is happening with 737... At least his dreck gave them hope... Lol.. | wolfofwallstreets |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions